NCT00155454View on ClinicalTrials.gov

Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Diabetes MellitusDiabetic RetinopathyVitreous Hemorrhage
Interventions
PROCEDURE

Intravitreal long acting gas (10% C3F8)

At the end of surgery, fluid-gas exchange with 10% C3F8 were done in the eye of study group

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00155454 - Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy | Biotech Hunter | Biotech Hunter